Larimar Therapeutics

Larimar Therapeutics Announces Issuance of U.S. Patent Providing Composition of Matter Protection for CTI-1601

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced the recent issuance of U.S. Patent No. 11,459,363. The patent, titled, “Materials and Methods for Treating Friedreich’s Ataxia,” provides composition …

Larimar Therapeutics Announces Issuance of U.S. Patent Providing Composition of Matter Protection for CTI-1601 Read More